Sign In
Buy FMS
$25.66
-0.0400 (-0.156%)
At Close: Jul 31, 2026
Fresenius: The Upside Is Getting Bigger
08:07am, Monday, 02'nd May 2022
Fresenius is an interesting investment - certainly in part because it doesn't require an ADR, you can invest in the medical care wing with the symbol FMS. The company's organic growth has been slowed
Fresenius Medical (FMS) Launches Campaign to Boost Kidney Care
01:33pm, Thursday, 14'th Apr 2022 Zacks Investment Research
Fresenius Medical's (FMS) My Reason campaign will help scientists understand genetic variations in patients with chronic kidney disease in a better way.
Fresenius Medical (FMS) Launches Campaign to Boost Kidney Care
11:18am, Thursday, 14'th Apr 2022
Fresenius Medical's (FMS) My Reason campaign will help scientists understand genetic variations in patients with chronic kidney disease in a better way.
My Dividend Stock Portfolio: March 2022 Update - 101 Holdings And 29 Buys
05:30am, Thursday, 07'th Apr 2022 Seeking Alpha
The war in Ukraine continues to dominate market movements. Read why I am not selling and predominantly focusing on adding dividend income via select purchases.
2 TeleHealth Stocks to Buy, 1 to Watch in 2022
03:23pm, Saturday, 02'nd Apr 2022 The Motley Fool
Patient care via phone and video is far from finished.
Fresenius Medical's (FMS) Merger Deal to Improve Kidney Care
02:04pm, Wednesday, 23'rd Mar 2022 Zacks Investment Research
Fresenius Medical's (FMS) merger deal to build an independent entity to transform kidney care and health equity throughout the United States.
Here’s Why Fresenius Medical Care (FMS) Landed in Artisan Partners’ Detractor List
05:20am, Tuesday, 01'st Mar 2022 Insider Monkey
Artisan Partners, a high value-added investment management firm, published its “Artisan Value Fund” fourth quarter 2021 investor letter – a copy of which can be downloaded here.
Is it Still Worthy to Keep Your Fresenius Medical Care (FMS) Shares?
05:15am, Thursday, 24'th Feb 2022 Insider Monkey
Artisan Partners, a high value-added investment management firm, published its ‘Artisan International Value Fund’ fourth quarter 2021 investor letter – a copy of which can be downloaded here.
Fresenius Medical (FMS) Q4 Earnings Beat Estimates, Up Y/Y
04:10pm, Wednesday, 23'rd Feb 2022 Zacks Investment Research
Fresenius Medical's (FMS) fourth-quarter earnings benefit from strong performance across all the geographic regions and segments.
Fresenius Medical (FMS) Q4 Earnings Beat Estimates, Up Y/Y
12:20pm, Wednesday, 23'rd Feb 2022
Fresenius Medical's (FMS) fourth-quarter earnings benefit from strong performance across all the geographic regions and segments.
DGAP-News: Fresenius Medical Care AG & Co. KGaA: Fresenius Medical Care published form 20-F for the fiscal year 2021
09:30am, Wednesday, 23'rd Feb 2022 BORSE ONLINE
DGAP-News: Fresenius Medical Care AG Co. KGaA / Key word(s): Annual Report Fresenius Medical Care AG Co. KGaA: Fresenius Medical Care published form 20-F for the fiscal year 2021 23.02.2022 / 10:30 The issuer is solely
Fresenius Medical Care AG & Co. KGaA. (FMS) CEO Rice Powell on Q4 2021 Results - Earnings Call Transcript
04:41pm, Tuesday, 22'nd Feb 2022
Fresenius Medical Care AG & Co. KGaA. (FMS) CEO Rice Powell on Q4 2021 Results - Earnings Call Transcript
Fresenius Medical Care Non-GAAP EPS of 0.90, revenue of 4.64B
02:58pm, Tuesday, 22'nd Feb 2022 Seeking Alpha
Fresenius Medical Care press release (FMS): Q4 Non-GAAP EPS of 0.90.Revenue of 4.64B (+5.5% Y/Y).
Fresenius Medical Care: Q4 Earnings Insights
02:27pm, Tuesday, 22'nd Feb 2022 Benzinga
Fresenius Medical Care (NYSE: FMS ) reported its Q4 earnings results on Tuesday, February 22, 2022 at 07:30 AM. Here''s what investors need to know about the announcement. Earnings Fresenius Medical Care beat estimated earnings by 4.08%, reporting an EPS of $0.51 Full story available on Benzinga.com
Fresenius Medical Care ADR Earnings, Revenue Beat in Q4 By Investing.com
12:08pm, Tuesday, 22'nd Feb 2022 Investing.com
Fresenius Medical Care ADR Earnings, Revenue Beat in Q4
